These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16482642)

  • 1. Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
    Jacobs-Kosmin D; Derk CT; Sandorfi N
    J Rheumatol; 2006 Mar; 33(3):629-32. PubMed ID: 16482642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantoprazole-induced acute interstitial nephritis.
    Moore I; Sayer JA; Nayar A; Ahmed S; Tapson JS
    J Nephrol; 2004; 17(4):580-1. PubMed ID: 15372423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabeprazole-induced acute interstitial nephritis.
    Geevasinga N; Coleman PL; Roger SD
    Nephrology (Carlton); 2005 Feb; 10(1):7-9. PubMed ID: 15705174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cephotaxime-associated allergic interstitial nephritis and MPO-ANCA positive vasculitis.
    Feriozzi S; Muda AO; Gomes V; Montanaro M; Faraggiana T; Ancarani E
    Ren Fail; 2000 Mar; 22(2):245-51. PubMed ID: 10803769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Leonhardt U; Ritzel U; Ramadori G
    Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
    [No Abstract]   [Full Text] [Related]  

  • 7. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute interstitial nephritis due to pantoprazole.
    Ra A; Tobe SW
    Ann Pharmacother; 2004 Jan; 38(1):41-5. PubMed ID: 14742791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with diffuse tubulointerstitial nephritis.
    Son D; Kanda H; Yamaguchi A; Kawabata K; Kawakami T; Kubo K; Higashihara M; Shimizu J; Uozaki H; Kuramochi S; Misaki Y; Takeuchi F; Yamamoto K
    J Nephrol; 2009; 22(3):417-20. PubMed ID: 19557721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump-inhibitor-induced hepatitis.
    Darabi K
    South Med J; 2005 Aug; 98(8):844-5. PubMed ID: 16144190
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug interactions. Proton pump inhibitors II].
    Zaigler M
    Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
    Sennaroglu E; Karakan S; Kayatas M; Akdur S; Genc H; Karakan T; Ucler R; Ozisler C; Urun Y
    Dig Dis Sci; 2006 Jan; 51(1):121-2. PubMed ID: 16416223
    [No Abstract]   [Full Text] [Related]  

  • 15. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
    Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
    J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
    Zhang AH; Chen M; Gao Y; Zhao MH; Wang HY
    Clin Immunol; 2007 Feb; 122(2):187-93. PubMed ID: 17070108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan's syndrome].
    Suzuki M; Arimura Y; Minoshima S; Fukuoka K; Miyake N; Ishizuka S; Soejima A; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1996 Sep; 38(9):423-7. PubMed ID: 8913096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.